Swiss - Delayed Quote CHF

PolyPeptide Group AG (PPGN.SW)

26.65

+0.05

+(0.19%)

As of 1:07:07 PM GMT+1. Market Open.

Cytovance Biologics and PolyPeptide Announce Collaboration for Microbial and Mammalian-Expressed Peptide Drugs

OKLAHOMA CITY & TORRANCE, Calif., January 13, 2025--This new collaboration provides a scalable, integrated solution for developing and manufacturing complex peptide drugs efficiently.

Business Wire yesterday

PPGN.SW
+0.19%
Donaldson and PolyPeptide Partner to Improve Sustainability in Peptide Manufacturing with Solvent Recovery Technology

MINNEAPOLIS & TORRANCE, Calif., May 13, 2024--Donaldson Company, Inc. (NYSE: DCI), a leading worldwide manufacturer of innovative filtration and separation products and solutions, and PolyPeptide Group AG (SIX: PPGN), a global leader in peptide manufacturing, today announced their collaboration on the development of a production scale solvent recovery system for use in peptide purification. Peptides are used as the active pharmaceutical ingredient (API) in therapeutic areas, which continue to br

Business Wire 7 months ago

PPGN.SW
+0.19%
DCI

Performance Overview

Return	PPGN.SW	MSCI WORLD
YTD	-6.16%	-1.12%
1-Year	+66.67%	+16.07%
3-Year	-72.99%	+15.57%